Skip to main content
. 2018 May 18;9(38):24927–24935. doi: 10.18632/oncotarget.24837

Figure 1. Percentage of HIV drug resistance-associated mutations to NRTIs, NNRTIs, PIs and INSTIs among 184 HIV-1-infected patients with GRT.

Figure 1